Cargando…
Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer
Endocrine therapy (ET) of selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs), and aromatase inhibitors (AIs) has been used as the gold standard treatment for hormone-receptor-positive (HR+) breast cancer. Despite its clinical benefits, approximately 30...
Autores principales: | Li, Chung-Liang, Moi, Sin-Hua, Lin, Huei-Shan, Hou, Ming-Feng, Chen, Fang-Ming, Shih, Shen-Liang, Kan, Jung-Yu, Kao, Chieh-Ni, Wu, Yi-Chia, Kao, Li-Chun, Chen, Ying-Hsuan, Lee, Yi-Chen, Chiang, Chih-Po |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501051/ https://www.ncbi.nlm.nih.gov/pubmed/36142451 http://dx.doi.org/10.3390/ijms231810539 |
Ejemplares similares
-
Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer
por: Hou, Ming-Feng, et al.
Publicado: (2021) -
Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer
por: Kan, Jung-Yu, et al.
Publicado: (2020) -
RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer
por: Kao, Chieh-Ni, et al.
Publicado: (2021) -
Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655
por: Kao, Chieh-Ni, et al.
Publicado: (2022) -
Using Deep Neural Network Approach for Multiple-Class Assessment of Digital Mammography
por: Hsu, Shih-Yen, et al.
Publicado: (2022)